secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2023-01-03T23:59:59+00:00
Accession:  0001104659-23-000422
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical enters ATM sales agreement with B. Riley for up to 4.9M shares
------------------------------------------------------------------------------

- Company may offer and sell up to 4,900,000 shares of common stock through Agent B. Riley Securities in at-the-market offerings.
- Sales require effectiveness of new S-3 registration statement filed December 30, 2022; Agent commission is 3.0% of gross proceeds.
- Company is not obligated to sell any shares; agreement continues until all shares sold or terminated by either party.
- Customary indemnification and expense reimbursement provided to Agent; offering may be conducted with price, time, or size limits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923000422/0001104659-23-000422-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923000422/tm231431d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-000422

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer